title: Mutagen sensitivity as measured by induced chromatid breakage as a marker of cancer risk.
abstract: Risk assessment is now recognized as a multidisciplinary process, extending beyond the scope of traditional epidemiologic methodology to include biological evaluation of interindividual differences in carcinogenic susceptibility. Modulation of environmental exposures by host genetic factors may explain much of the observed interindividual variation in susceptibility to carcinogenesis. These genetic factors include, but are not limited to, carcinogen metabolism and DNA repair capacity. This chapter describes a standardized method for the functional assessment of mutagen sensitivity. This in vitro assay measures the frequency of mutagen-induced breaks in the chromosomes of peripheral blood lymphocytes. Mutagen sensitivity assessed by this method has been shown to be a significant risk factor for tobacco-related maladies, especially those of the upper aerodigestive tract. Mutagen sensitivity may therefore be a useful member of a panel of susceptibility markers for defining high-risk subgroups for chemoprevention trials. This chapter describes methods for and discusses results from studies of mutagen sensitivity as measured by quantifying chromatid breaks induced by clastogenic agents, such as the γ-radiation mimetic DNA cross-linking agent bleomycin and chemicals that form so-called bulky DNA adducts, such as 4-nitroquinoline and the tobacco smoke constituent benzo[a]pyrene, in short-term cultured peripheral blood lymphocytes.
authors.affiliation: Department of Epidemiology, M.D. Anderson Cancer Center, University of Texas, 1515 Holcombe Blvd., Box 189, Houston, TX, 77030, USA, xwu@mdanderson.org.
authors.forename: Xifeng
authors.initials: X
authors.lastname: Wu
authors.forename: Yun-Ling
authors.initials: YL
authors.lastname: Zheng
authors.forename: T C
authors.initials: TC
authors.lastname: Hsu
mesh_terms: D015112:4-Nitroquinoline-1-oxide / Q000633:toxicity; D015123:7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide / Q000633:toxicity; D001761:Bleomycin / Q000633:toxicity; D002478:Cells, Cultured; D002842:Chromatids / Q000235:genetics*; D053903:DNA Breaks, Double-Stranded; D005819:Genetic Markers; D020022:Genetic Predisposition to Disease; D006801:Humans; D008214:Lymphocytes / Q000187:drug effects / Q000502:physiology / Q000528:radiation effects; D009153:Mutagens / Q000633:toxicity*; D009369:Neoplasms / Q000139:chemically induced / Q000235:genetics*; D015363:Quinolones / Q000633:toxicity; D011832:Radiation Injuries / Q000235:genetics; D012306:Risk
chemical_list: C120195:4-nitroquinolone-1-oxide; D005819:Genetic Markers; D009153:Mutagens; D015363:Quinolones; D001761:Bleomycin; D015123:7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide; D015112:4-Nitroquinoline-1-oxide